mardi 15 décembre 2015

Onco Actu du 15 décembre 2015

1. Biologie

Local protein factories make cancer cells motile [The Institute of Cancer Research]

Two Small RNAs, Often Missing from Cancer Cells, May Suppress Tumors [National Cancer Institute]

4. Dépistage, diagnostic et pronostic

The New Health Care: Even in Basic Health Decisions, You Can’t Screen Out Politics [NY Times]

4.2 Dép., diag. & prono. - Génome

Study uncovers hard-to-detect cancer mutations ​[Washington University in St. Louis]

4.7 Dép., diag. & prono. - Col de l'utérus

Five Factors Identify Subset of Patients With Advanced Cervical Cancer Who May Not Benefit From Bevacizumab Treatment [AACR]

5.10 Traitements - Essais

Clinical trials are subjecting cancer patients to too many biopsies, study finds [STAT]

5.12 Immunothérapies

Cancer Immunotherapy ETF Offers High Growth Investing Potential [TheStreet]

5.2 Pharma

Amgen reacquires rights to three drugs from Glaxo in 48 countries [Reuters]

5.2.1 Pharma - Partenariats

Bristol-Myers Squibb and UCLA Enter into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Research Program [BMS]

5.4 Traitements - Economie

NICE intends to recommend olaparib for ovarian, fallopian tube and peritoneal cancer after company provides more information [NICE]

Drug approvals top 2014 high but R&D returns still struggle [Reuters]

6. Lutte contre les cancers

Cannabis & Cancer: Cause, Cure, Conundrum [Colorado Cancer Blogs]

6.1 Observation

Pregnancy does not increase risk of Hodgkin lymphoma recurrence [Karolinska Institutet]

6.11 Patients

Woman with breast cancer gives birth prematurely to undergo treatment [The Guardian]

6.3 Associations

Misleading analysis of charity spending: Our response [Cancer Research UK]

6.6 Publications

Cancer research pioneer Robert Weinberg corrected Oncogene paper [Retraction Watch]

6.9 Controverses

Reporting Clinical Trials: Nothing Happens When Nothing Happens [In the Pipeline]